Scientific Sessions 2024  /  Annual Lipid Updates - 2024  /  Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies
Logo

American Heart Association

  113
  0

Final ID:

Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies

  • Yeang, Calvin  ( University of California San Diego , San Diego , California , United States )
  • Bhatia, Harpreet  ( University of California San Diego , San Diego , California , United States )
  • Mehta, Anurag  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
    • Author Disclosures:
    Calvin Yeang: No Answer | Harpreet Bhatia: DO have relevant financial relationships ; Consultant:Kaneka:Past (completed) ; Advisor:Arrowhead:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Consultant:Novartis:Active (exists now) | Anurag Mehta: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Annual Lipid Updates - 2024

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
The Role of Advanced Lipid Testing in 2024

Shapiro Michael, Gianos Eugenia, Taub Pam, Wilkinson Michael

New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

More abstracts from these authors:
Lp(a) may be little but has might: a review of recent lp(a) lowering trials

Bajaj Archna, Yeang Calvin

Managing Obesity and MASLD - Whose Job Is It?

Jastreboff Ania, Woodhouse Sheila, Mehta Anurag

You have to be authorized to contact abstract author. Please, Login
Not Available